Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Variable definitions of the influenza season and their impact on vaccine effectiveness estimates.

Sullivan SG, Tay EL, Kelly H.

Vaccine. 2013 Sep 13;31(40):4280-3. doi: 10.1016/j.vaccine.2013.06.103.

PMID:
23850417
2.

Using sentinel surveillance to monitor effectiveness of influenza vaccine is feasible: a pilot study in Denmark.

Mazick A, Christiansen AH, Samuelsson S, Mølbak K.

Euro Surveill. 2006;11(10):254-6.

PMID:
17130655
3.

Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.

Skowronski DM, Masaro C, Kwindt TL, Mak A, Petric M, Li Y, Sebastian R, Chong M, Tam T, De Serres G.

Vaccine. 2007 Apr 12;25(15):2842-51.

PMID:
17081662
4.

Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010.

Savulescu C, Jiménez-Jorge S, de Mateo S, Pozo F, Casas I, Breña PP, Galmés A, Vanrell JM, Rodriguez C, Vega T, Martinez A, Torner N, Ramos JM, Serrano MC, Castilla J, Cenoz MG, Altzibar JM, Arteagoitia JM, Quiñones C, Perucha M, Larrauri A.

BMC Public Health. 2011 Nov 30;11:899. doi: 10.1186/1471-2458-11-899.

5.

Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2008 Apr 18;57(15):393-8.

6.

Estimation of influenza vaccine effectiveness from routine surveillance data.

Kelly H, Carville K, Grant K, Jacoby P, Tran T, Barr I.

PLoS One. 2009;4(3):e5079. doi: 10.1371/journal.pone.0005079.

8.

I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe.

Kissling E, Valenciano M, Cohen JM, Oroszi B, Barret AS, Rizzo C, Stefanoff P, Nunes B, Pitigoi D, Larrauri A, Daviaud I, Horvath JK, O'Donnell J, Seyler T, Paradowska-Stankiewicz IA, Pechirra P, Ivanciuc AE, Jiménez-Jorge S, Savulescu C, Ciancio BC, Moren A.

PLoS One. 2011;6(11):e27622. doi: 10.1371/journal.pone.0027622.

10.

Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011.

Kelly HA, Sullivan SG, Grant KA, Fielding JE.

Influenza Other Respir Viruses. 2013 Sep;7(5):729-37. doi: 10.1111/irv.12018.

11.

Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study.

Valenciano M, Kissling E, Cohen JM, Oroszi B, Barret AS, Rizzo C, Nunes B, Pitigoi D, Larrauri Cámara A, Mosnier A, Horvath JK, O'Donnell J, Bella A, Guiomar R, Lupulescu E, Savulescu C, Ciancio BC, Kramarz P, Moren A.

PLoS Med. 2011 Jan;8(1):e1000388. doi: 10.1371/journal.pmed.1000388.

12.

Interim adjusted estimates of seasonal influenza vaccine effectiveness - United States, February 2013.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2013 Feb 22;62(7):119-23.

13.

Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study.

Szilagyi PG, Fairbrother G, Griffin MR, Hornung RW, Donauer S, Morrow A, Altaye M, Zhu Y, Ambrose S, Edwards KM, Poehling KA, Lofthus G, Holloway M, Finelli L, Iwane M, Staat MA; New Vaccine Surveillance Network..

Arch Pediatr Adolesc Med. 2008 Oct;162(10):943-51. doi: 10.1001/archpedi.162.10.943.

PMID:
18838647
14.

Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.

Belongia EA, Kieke BA, Donahue JG, Greenlee RT, Balish A, Foust A, Lindstrom S, Shay DK; Marshfield Influenza Study Group..

J Infect Dis. 2009 Jan 15;199(2):159-67. doi: 10.1086/595861.

15.

Surveillance of influenza vaccination coverage--United States, 2007-08 through 2011-12 influenza seasons.

Lu PJ, Santibanez TA, Williams WW, Zhang J, Ding H, Bryan L, O'Halloran A, Greby SM, Bridges CB, Graitcer SB, Kennedy ED, Lindley MC, Ahluwalia IB, LaVail K, Pabst LJ, Harris L, Vogt T, Town M, Singleton JA; Centers for Disease Control and Prevention (CDC)..

MMWR Surveill Summ. 2013 Oct 25;62(4):1-28.

16.

Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008.

Fielding JE, Grant KA, Papadakis G, Kelly HA.

BMC Infect Dis. 2011 Jun 14;11:170. doi: 10.1186/1471-2334-11-170.

17.

Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants.

Janjua NZ, Skowronski DM, De Serres G, Dickinson J, Crowcroft NS, Taylor M, Winter AL, Hottes TS, Fonseca K, Charest H, Drews SJ, Sabaiduc S, Bastien N, Li Y, Gardy JL, Petric M.

J Infect Dis. 2012 Jun 15;205(12):1858-68. doi: 10.1093/infdis/jis283.

18.

Early estimates of 2014/15 seasonal influenza vaccine effectiveness in preventing influenza-like illness in general practice using the screening method in France.

Souty C, Blanchon T, Bonmarin I, Lévy-Bruhl D, Behillil S, Enouf V, Valette M, Bouscambert M, Turbelin C, Capai L, Roussel V, Hanslik T, Falchi A.

Hum Vaccin Immunother. 2015;11(7):1621-5. doi: 10.1080/21645515.2015.1046661.

19.
20.

First estimates of influenza vaccine effectiveness among severe influenza cases, France, 2011/12.

Bonmarin I, Belchior E, Le Strat Y, Levy-Bruhl D.

Euro Surveill. 2012 May 3;17(18). pii: 20163.

Items per page

Supplemental Content

Support Center